Stocktoria

IRADIMED CORP IRMD

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2014-07-16 · LEI

IRADIMED CORP statistics & valuation

P / E53.4×
P / S14.3×
P / B12.7×
P / FCF69.9×
Net margin26.8%
FCF margin20.5%
Return on capital26.5%
Graham number -80.5%$17.02

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($17.02); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
22.20% 2.20% 20.70% 25.00% 4.30% 22.30% 24.10% 26.20% 26.30% 26.80% 2016201720182019202020212022202320242025
Gross margin (%)
81.10% 75.90% 76.30% 77.10% 74.30% 76.60% 77.40% 76.50% 76.90% 76.70% 2016201720182019202020212022202320242025
Operating margin (%)
33.60% 5.60% 19.70% 22.50% -2.40% 23.50% 29.30% 30.60% 30.00% 31.20% 2016201720182019202020212022202320242025
Return on equity (%)
22.60% 1.50% 15.00% 17.30% 2.20% 12.90% 17.40% 24.10% 22.20% 23.80% 2016201720182019202020212022202320242025
Shares outstanding
12.0M 11.7M 12.1M 12.3M 12.4M 12.6M 12.6M 12.7M 12.8M 12.9M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
19.40% 1.30% 13.00% 14.40% 1.90% 11.30% 15.00% 18.70% 19.60% 20.70% 2016201720182019202020212022202320242025
Free cash flow margin (%)
26.50% 11.40% 23.50% 25.60% 16.90% 25.80% 17.30% 9.20% 24.10% 20.50% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
$0.60 $0.04 $0.52 $0.78 $0.11 $0.74 $1.02 $1.35 $1.50 $1.75 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

IRADIMED CORP trades at about 49.9× earnings — near its 10-year norm (10-year range 15.2×–371.3×, median 52.7×).

15.2× 371.3×

Shaded band = 10-year range (15.2×–371.3×); dot = today's 49.9×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin76.7%76.9%76.5%77.4%76.6%74.3%77.1%76.3%75.9%81.1%
Operating margin31.2%30.0%30.6%29.3%23.5%-2.4%22.5%19.7%5.6%33.6%
Net margin26.8%26.3%26.2%24.1%22.3%4.3%25.0%20.7%2.2%22.2%
FCF margin20.5%24.1%9.2%17.3%25.8%16.9%25.6%23.5%11.4%26.5%
Return on assets20.7%19.6%18.7%15.0%11.3%1.9%14.4%13.0%1.3%19.4%
Return on equity23.8%22.2%24.1%17.4%12.9%2.2%17.3%15.0%1.5%22.6%
Current ratio7.988.844.659.0611.1812.9610.069.508.619.25

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.